Tumor antigen-specific T helper cells in cancer immunity and immunotherapy

Keith L. Knutson(Mayo Clinic), Mary L. Disis(University of Washington)

Cancer Immunology Immunotherapy

January 26, 2005

10.1007/s00262-004-0653-2

Cited by 676Open Access

Abstract

Related Papers

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Glen Dranoff, Elizabeth M. Jaffee, A Lazenby et al.|Proceedings of the National Academy of Sciences|1993|2.8k

SYFPEITHI: database for MHC ligands and peptide motifs

Hans‐Georg Rammensee, Jutta Bachmann, Niels Emmerich et al.|Immunogenetics|1999|2.3k

Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires

Scott Southwood, John Sidney, Akihiro Kondo et al.|The Journal of Immunology|1998|659

Generation of T-Cell Immunity to the HER-2/neu Protein After Active Immunization With HER-2/neu Peptide–Based Vaccines

Mary L. Disis, Theodore A. Gooley, Kristine Rinn et al.|Journal of Clinical Oncology|2002|425

Antigen presentation by MHC class I and its regulation by interferon γ

Klaus Früh, Young Yang|Current Opinion in Immunology|1999|294